GlaxoSmithKline
GSK
#250
Rank
A$123.31 B
Marketcap
$60.46
Share price
0.78%
Change (1 day)
-6.90%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $5.27

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $5.63. In 2022 the company made an earnings per share (EPS) of $13.64 an increase over its 2021 EPS that were of $4.81.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.27-61.36%
2022$13.64183.39%
2021$4.81-17.83%
2020$5.8621.82%
2019$4.8123.91%
2018$3.88141.48%
2017$1.6164.6%
2016$0.98-90.64%
2015$10.43178.14%
2014$3.75-48.16%
2013$7.2322.63%
2012$5.90-11.32%
2011$6.65230.25%
2010$2.01-70.98%
2009$6.946.76%
2008$6.50-15.14%
2007$7.667.82%
2006$7.1119.61%
2005$5.9418.56%
2004$5.010.36%
2003$4.9950.39%
2002$3.3231.13%
2001$2.53-25.43%
2000$3.4031.58%
1999$2.581.05%
1998$2.55-0.98%
1997$2.58-10.07%
1996$2.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.19-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.99-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.93-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.02 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.12-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$3.22-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.40-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA